Biosimilar medicine fact sheet – adalimumab

This fact sheet provides information about biosimilar brands of adalimumab listed on the Pharmaceutical Benefits Scheme (PBS).

Scroll down to access downloads and media.

Amgevita®, Hadlima ®, Hyrimoz® and Idacio® were listed on the PBS on 1 April 2021 under the PBS General Schedule and the Section 100 Highly Specialised Drugs Program.

About this resource

Publication date:

October 2024

Publication type:

Fact sheet

Audience:

General public

Language:

English

Part of a collection:

Tags: